Company intelligence / Profile preview
Innate Pharma
- Ownership
- Public · IPHA
- Employees
- ~168
- Development stage
- Phase 3
Overview
Innate Pharma has a diversified clinical pipeline focused on immunotherapies for cancer. Lead assets include lacutamab in advanced cutaneous and peripheral T-cell lymphomas; monalizumab with AstraZeneca in NSCLC; several multi-specific NK cell engagers from the ANKET® platform targeting hematologic malignancies and solid tumors; and the ADC IPH4502 targeting Nectin‑4-expressing solid tumors now in Phase 1 trials. Early data show promise for efficacy across multiple tumor types with differentiated mechanisms of action.
- Therapeutic areas
- OncologyHematology
- Modalities
- Monoclonal antibodies (mAbs)Multi-specific NK cell engagersAntibody-drug conjugates (ADCs)
- Industry
- Biotech
Drug pipeline
15 assets14 more assets in the full pipeline.
Request access →Partnerships
Financials
- Market cap
- $192.5M
- Total revenue
- $-2.1M
- Enterprise value
- $180.8M
Beyond the preview
Go deeper on Innate Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Innate Pharma.